| Pharmaceutical Information |
| Drug Name |
Pegademase (bovine) |
| Drug ID |
BADD_D01689 |
| Description |
Bovine adenosine deaminase derived from bovine intestine that has been extensively pegylated for extended serum half life. |
| Indications and Usage |
For treatment of adenosine deaminase deficiency |
| Marketing Status |
approved |
| ATC Code |
L03AX04 |
| DrugBank ID |
DB00061
|
| KEGG ID |
D05384
|
| MeSH ID |
C051409
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D0H1WY
|
| NDC Product Code |
Not Available |
| UNII |
Not Available
|
| Synonyms |
pegademase bovine | pegademase | polyethylene glycol-modified adenosine deaminase | PEG-ADA | pegADA |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
130167-68-9 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
